Trusted News Discovery Since 2008
{{/content}}
United States: Updates On Aflibercept BPCIA Litigation - Goodwin Procter LLP
Credit: Mondaq- Published on March 26, 2024
As we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") filed a motion seeking to establish a multi-district litigation ("MDL")...
You are here
Related news from verified sources
On March 4, Biocon Biologics Ltd. announced it has signed a settlement agreement with Bayer Inc. and Regeneron Pharmaceuticals, Inc. regarding YESAFILI, Biocon's...
on March 15, 2024 • Mondaq
Until recently, Delaware law offered no clear standard of review for a controller's exercise of stockholder voting power.
on March 15, 2024 • Mondaq